Edgewise Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Edgewise Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Edgewise Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Edgewise Therapeutics by T. Rowe Price Associates
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $300k | 16k | 18.27 |
2023-12-31 | $1.4M | 126k | 10.95 |
2023-09-30 | $721k | 126k | 5.74 |
2023-06-30 | $967k | 125k | 7.76 |
2023-03-31 | $819k | 123k | 6.68 |
2022-12-31 | $2.3M | 258k | 8.94 |
2022-03-31 | $3.4M | 350k | 9.70 |